FIIs cut stake in Biocon during Q3

09 Jan 2015 Evaluate

Foreign institutional investors (FIIs) have decreased their holdings in Biocon by over 200 basis points to 10.62% at the end of the third quarter from 13.05% in the second quarter ended September 30, 2014. The Foreign investors have sold 48.6 lakh shares representing 2.43% stake of Biocon during the recently concluded quarter.

On the other hand, domestic institutional investors’ (DIIs’) shareholding in the company has increased by 65 basis points to 7.60% from 6.95% in past three months.

Biocon is India’s largest and Asia’s leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×